Boston Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,403
Closed -$464K 740
2022
Q2
$464K Buy
30,403
+126
+0.4% +$2.27K ﹤0.01% 614
2022
Q1
$640K Buy
30,277
+882
+3% +$19K ﹤0.01% 599
2021
Q4
$695K Hold
29,395
﹤0.01% 578
2021
Q3
$590K Sell
29,395
-4,235
-13% -$86.8K ﹤0.01% 591
2021
Q2
$676K Sell
33,630
-715
-2% -$15.3K ﹤0.01% 595
2021
Q1
$731K Sell
34,345
-2,864
-8% -$61.6K ﹤0.01% 612
2020
Q4
$811K Sell
37,209
-3,153
-8% -$61.4K ﹤0.01% 565
2020
Q3
$712K Sell
40,362
-5,560
-12% -$103K ﹤0.01% 577
2020
Q2
$863K Sell
45,922
-23,886
-34% -$423K ﹤0.01% 556
2020
Q1
$1.21M Sell
69,808
-6,594
-9% -$138K ﹤0.01% 495
2019
Q4
$1.61M Sell
76,402
-14,124
-16% -$286K ﹤0.01% 531
2019
Q3
$1.77M Sell
90,526
-1,222
-1% -$22.4K ﹤0.01% 520
2019
Q2
$1.6M Sell
91,748
-12,510
-12% -$225K ﹤0.01% 565
2019
Q1
$1.93M Buy
104,258
+1,350
+1% +$24.1K ﹤0.01% 554
2018
Q4
$1.66M Buy
+102,908
New +$1.63M ﹤0.01% 579

Other funds holding MPT

Boston Partners's MPT Position: Q3 2022 in Review

Boston Partners sold out of Medical Properties Trust (MPT) in Q3 2022, closing a stake of 30,403 shares — an estimated $464K sold.

Boston Partners first reported a position in MPT in Q4 2018 and held it in 15 quarters. The position peaked at $1.93M in Q1 2019. 601 funds tracked by Wall St. Rank hold MPT as of Q3 2022.

  • Boston Partners reported no remaining Medical Properties Trust position as of Q3 2022 after selling out during the quarter.
  • Boston Partners sold 30,403 Medical Properties Trust shares in Q3 2022, an estimated $464K.
  • Boston Partners first reported a position in Medical Properties Trust in Q4 2018 and held it in 15 quarters.
  • Boston Partners's Medical Properties Trust position peaked at $1.93M in Q1 2019.
  • 601 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2022.

Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.